Results for “”

Entry Author Date Location
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership 07/09/20 Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
PacBio CEO, CFO Plan Retirements and More People on the Move 07/07/20 National
MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy 07/02/20 San Diego
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity 07/01/20 Europe
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases 07/01/20 Boston
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug 06/29/20 San Diego
With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash 06/26/20 National
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis 06/24/20 National
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance 06/16/20 San Francisco
Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel 06/16/20 Philadelphia
Jazz Pharma Gets Quick FDA OK for New Small Cell Lung Cancer Drug 06/15/20 National
FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 06/15/20 National
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Accent, AstraZeneca Ink Cancer Drug Deal to Block RNA-Modifying Proteins 06/04/20 Boston
NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation 06/03/20 Boston
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Page 1 of 5 next page »